GUIDELINESANDSTANDARDS

AmericanSocietyofEchocardiographyClinicalRecommendationsforMultimodalityCardiovascular

ImagingofPatientswithHypertrophic

Cardiomyopathy

EndorsedbytheAmericanSocietyofNuclearCardiology,SocietyforCardiovascularMagneticResonance,andSocietyofCardiovascular

ComputedTomography

SherifF.Nagueh,MD,FASE,Chair,*S.MichelleBierig,RDCS,FASE,*MatthewJ.Budoff,MD,§MilindDesai,MD,*VaskenDilsizian,MD, BenjaminEidem,MD,FASE,*StevenA.Goldstein,MD,*JudyHung,MD,FASE,*MartinS.Maron,MD, SteveR.Ommen,MD,*andAnnaWoo,MD,*Houston,Texas;

St.Louis,Missouri;LosAngeles,California;Cleveland,Ohio;Baltimore,Maryland;Rochester,Minnesota;

Washington,DistrictofColumbia;Boston,Massachusetts;Toronto,Ontario,Canada

(JAmSocEchocardiogr2011;24:473-98.)

Keywords:Hypertrophiccardiomyopathy,Echocardiography,Nuclearimaging,Cardiovascularmagneticres-onance,Cardiaccomputedtomography

FromtheMethodistDeBakeyHeartandVascularCenter,Houston,Texas(S.F.N.);St.Anthony’sMedicalCenter,St.Louis,Missouri(S.M.B.);LosAngelesBiomedicalResearchInstitute,Torrance,California(M.J.B.);ClevelandClinic,Cleveland,Ohio(M.D.);theUniversityofMarylandSchoolofMedicine,Baltimore,Maryland(V.D.);MayoClinic,Rochester,Minnesota(B.E.,S.R.O.);WashingtonHospitalCenter,Washington,DistrictofColumbia(S.A.G.);MassachusettsGeneralHospital,Boston,Massachusetts(J.H.);TuftsMedicalCenter,Boston,Massachusetts(M.S.M.);andTorontoGeneralHospital,UniversityofToronto,Toronto,Ontario,Canada(A.W.).

Thefollowingauthorsreportednoactualorpotentialcon ictsofinterestinrelationtothisdocument:SherifF.Nagueh,MD,FASE,S.MichelleBierig,RDCS,FASE,MatthewJ.Budoff,MD,MilindDesai,MD,VaskenDilsizian,MD,BenjaminEidem,MD,FASE,StevenA.Goldstein,MD,JudyHung,MD,FASE,SteveR.Ommen,MD,andAnnaWoo,MD.Thefollowingauthorreportedarelationshipwithoneormorecommercialinterests:MartinS.Maron,MD,servesasaconsultantforPGxHealth.

TABLEOFCONTENTS

Abbreviations474

OrganizationoftheWritingGroupandEvidenceReview474

1.Introduction474

2.Echocardiography474

A.CardiacStructure474

B.AssessmentofLVSystolicFunction475C.AssessmentofLVDiastolicFunction477

D.DynamicObstructionandMitralValveAbnormalities477E.MitralRegurgitationinHCM480

F.MyocardialIschemia,Fibrosis,andMetabolism481G.GuidanceofSeptalReductionProcedures481

i.SurgicalMyectomy481ii.AlcoholSeptalAblation481iii.PermanentPacing483

H.ScreeningandPreclinicalDiagnosis4833.NuclearImaging484

A.CardiacStructure484

B.RadionuclideAngiographyforLVSystolicFunction484C.RadionuclideAngiographyforLVDiastolicFunction484D.DynamicObstructionandMitralValveAbnormalities484E.MitralRegurgitationinHCM484

F.MyocardialIschemia,Fibrosis,andMetabolism484

i.SPECT484

ii.PositronEmissionTomography(PET)485iii.ImagingMetabolism486

G.GuidanceofSeptalReductionProcedures486H.ScreeningandPreclinicalDiagnosis4863.CardiovascularMagneticResonance486

A.CardiacStructure486

B.AssessmentofLVSystolicFunction487C.AssessmentofLVDiastolicFunction

487

Reprintrequests:AmericanSocietyofEchocardiography,2100GatewayCentreBoulevard,Suite310,Morrisville,NC27560(E-mail:ase@http://www.51wendang.com).

WritingGroupofthe*AmericanSocietyofEchocardiography(ASE) AmericanSocietyofNuclearCardiology, SocietyforCardiovascularMagneticResonance,and§SocietyofCardiovascularComputedTomography.0894-7317/$36.00

Copyright2011bytheAmericanSocietyofEchocardiography.doi:10.1016/j.echo.2011.03.006

473